Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Clive McCarthy & Edward Walker. (2014) Tropomyosin receptor kinase inhibitors: a patent update 2009 – 2013. Expert Opinion on Therapeutic Patents 24:7, pages 731-744.
Read now
Read now
Nicola Arrighi, Serena Bodei, Danilo Zani, Claudio Simeone, Sergio Cosciani Cunico, Cristina Missale, Pierfranco Spano & Sandra Sigala. (2010) Nerve growth factor signaling in prostate health and disease. Growth Factors 28:3, pages 191-201.
Read now
Read now
Tao Wang, Dingwei Yu & Michelle L Lamb. (2009) Trk kinase inhibitors as new treatments for cancer and pain. Expert Opinion on Therapeutic Patents 19:3, pages 305-319.
Read now
Read now
Stephan L. Haas, Stephan L. Haas, Brit Fitzner, Stephan L. Haas, Brit Fitzner, Robert Jaster, Eliza Wiercinska, Haristi Gaitantzi, Ralf Jesenowski, J.-Matthias Löhr, Manfred V. Singer, Steven Dooley & Katja Breitkopf. (2009) Transforming growth factor-β induces nerve growth factor expression in pancreatic stellate cells by activation of the ALK-5 pathway. Growth Factors 27:5, pages 289-299.
Read now
Read now
Gerasimos P Sykiotis & Athanasios G Papavassiliou. (2007) Targeting the nerve growth factor network in Alzheimer’s disease. Expert Opinion on Investigational Drugs 16:3, pages 267-269.
Read now
Read now
Articles from other publishers (30)
Marzia Di Donato, Giovanni Galasso, Pia Giovannelli, Antonio A. Sinisi, Antimo Migliaccio & Gabriella Castoria. (2021) Targeting the Nerve Growth Factor Signaling Impairs the Proliferative and Migratory Phenotype of Triple-Negative Breast Cancer Cells. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Amir-Hassan Zarnani, Davood Jafari, Mahmood Bozorgmehr, Mahdi Shabani, Leila Barzegar-Yarmohammadi, Fatemeh Ghaemimanesh & Mahmood Jeddi-Tehrani. 2021. Cancer Immunology. Cancer Immunology
273
312
.
Álvaro González, Cira García de Durango, Verónica Alonso, Beatriz Bravo, Arancha Rodríguez de Gortázar, Alan Wells, Jerónimo Forteza & Fernando Vidal-Vanaclocha. (2017) Distinct Osteomimetic Response of Androgen-Dependent and Independent Human Prostate Cancer Cells to Mechanical Action of Fluid Flow: Prometastatic Implications. The Prostate 77:3, pages 321-333.
Crossref
Crossref
Daehyun Kim, Jung Youl Park & Ji-Hyun Kim. (2017)
Docking-based
In Silico
Screening for Identification of Micromolar Inhibitors of Tropomyosin-related Kinase A from Natural Origin
. Bulletin of the Korean Chemical Society 38:2, pages 205-210.
Crossref
Crossref
Mohammad Sayed Alam, Sang-Un Choi & Dong-Ung Lee. (2017) Synthesis, anticancer, and docking studies of salicyl-hydrazone analogues: A novel series of small potent tropomyosin receptor kinase A inhibitors. Bioorganic & Medicinal Chemistry 25:1, pages 389-396.
Crossref
Crossref
Jaana Tammiku-Taul, Rahel Park, Kaur Jaanson, Kristi Luberg, Dimitar A. Dobchev, Dzmitry Kananovich, Artur Noole, Merle Mandel, Allen Kaasik, Margus Lopp, Tõnis Timmusk & Mati Karelson. (2016) Indole-like Trk receptor antagonists. European Journal of Medicinal Chemistry 121, pages 541-552.
Crossref
Crossref
Ihsan Ekin Demir, Elke Tieftrunk, Stephan Schorn, Helmut Friess & Güralp O. Ceyhan. (2016) Nerve growth factor & TrkA as novel therapeutic targets in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1866:1, pages 37-50.
Crossref
Crossref
Amir-Hassan Zarnani, Mahmood Bozorgmehr, Mahdi Shabani, Leila Barzegar-Yarmohammadi, Fatemeh Ghaemimanesh & Mahmood Jeddi-Tehrani. 2015. Cancer Immunology. Cancer Immunology
293
328
.
SHENGLIANG HUANG, XUEBEI ZHANG, LIUYU XU, QING LI & QINGLI ZHAO. (2014) Expression of nerve growth factor in the prostate of male rats in response to chronic stress and sympathetic denervation. Experimental and Therapeutic Medicine 8:4, pages 1237-1240.
Crossref
Crossref
Carol A Podlasek, Rudrani Ghosh, Omer Onur Cakir, Christopher Bond, Kevin E McKenna & Kevin T McVary. (2013) Nerve growth factor signaling following unilateral pelvic ganglionectomy in the rat ventral prostate is age dependent. Asian Journal of Andrology 15:6, pages 764-769.
Crossref
Crossref
Grazia Pula, Alessandra Pistilli, Claudia Montagnoli, Anna M. Stabile, Maria G. Rambotti & Mario Rende. (2013) The tricyclic antidepressant amitriptyline is cytotoxic to HTB114 human leiomyosarcoma and induces p75NTR-dependent apoptosis. Anti-Cancer Drugs 24:9, pages 899-910.
Crossref
Crossref
Ji Yea Kim, Chun Jeih Ryu & Hwangseo Park. (2013) Effects of Tropomyosin-Related Kinase A Inhibitors on the Proliferation of Human Lung Cancer Cells. Bulletin of the Korean Chemical Society 34:4, pages 1293-1295.
Crossref
Crossref
Glen J. Weiss, Manuel Hidalgo, Mitesh J. Borad, Daniel Laheru, Raoul Tibes, Ramesh K. Ramanathan, Lisa Blaydorn, Gayle Jameson, Antonio Jimeno, Jeffrey D. Isaacs, Angela Scaburri, Maria Adele Pacciarini, Francesco Fiorentini, Marina Ciomei & Daniel D. Von Hoff. (2011) Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies. Investigational New Drugs 30:6, pages 2334-2343.
Crossref
Crossref
Francesca Bedussi, Serena Bodei, Martina Fragni, Danilo Zani, Claudio Simeone, Sergio Cosciani Cunico, Pier Franco Spano & Sandra Sigala. (2012) GPNMB/Osteoactivin as a Malignancy Biomarker in an Experimental Model of Human Prostate Adenocarcinoma. Urologia Journal 79:4, pages 240-246.
Crossref
Crossref
T. Bertrand, M. Kothe, J. Liu, A. Dupuy, A. Rak, P.F. Berne, S. Davis, T. Gladysheva, C. Valtre, J.Y. Crenne & M. Mathieu. (2012) The Crystal Structures of TrkA and TrkB Suggest Key Regions for Achieving Selective Inhibition. Journal of Molecular Biology 423:3, pages 439-453.
Crossref
Crossref
Hwangseo Park, Okyung Chi, Jinhee Kim & Sungwoo Hong. (2011) Identification of Novel Inhibitors of Tropomyosin-Related Kinase A through the Structure-Based Virtual Screening with Homology-Modeled Protein Structure. Journal of Chemical Information and Modeling 51:11, pages 2986-2993.
Crossref
Crossref
Yi Ye, Dongmin Dang, Jianan Zhang, Chi T. Viet, David K. Lam, John C. Dolan, Jennifer L. Gibbs & Brian L. Schmidt. (2011) Nerve Growth Factor Links Oral Cancer Progression, Pain, and Cachexia. Molecular Cancer Therapeutics 10:9, pages 1667-1676.
Crossref
Crossref
Elsa Vanhecke, Eric Adriaenssens, Stéphanie Verbeke, Samuel Meignan, Emmanuelle Germain, Nathalie Berteaux, Victor Nurcombe, Xuefen Le Bourhis & Hubert Hondermarck. (2011) Brain-Derived Neurotrophic Factor and Neurotrophin-4/5 Are Expressed in Breast Cancer and Can Be Targeted to Inhibit Tumor Cell Survival. Clinical Cancer Research 17:7, pages 1741-1752.
Crossref
Crossref
Richard J. Warrington & Keith E. Lewis. (2010) Natural antibodies against nerve growth factor inhibit in vitro prostate cancer cell metastasis. Cancer Immunology, Immunotherapy 60:2, pages 187-195.
Crossref
Crossref
Yue Qian, Satoshi Takeuchi, Shan‐Juan Chen, Long Dugu, Gaku Tsuji, Lining Xie, Takeshi Nakahara, Yoichi Moroi, Ya‐Ting Tu & Masutaka Furue. (2010) Nerve growth factor, brain‐derived neurotrophic factor and their high‐affinity receptors are overexpressed in extramammary Paget's disease. Journal of Cutaneous Pathology 37:11, pages 1150-1154.
Crossref
Crossref
Chann Lagadec, Rodrigue Romon, Christophe Tastet, Samuel Meignan, Emmanuelle Com, Adeline Page, Gabriel Bidaux, Hubert Hondermarck & Xuefen Le Bourhis. (2010) Ku86 is important for TrkA overexpression-induced breast cancer cell invasion. PROTEOMICS - Clinical Applications 4:6-7, pages 580-590.
Crossref
Crossref
Mario Rende, Maria G. Rambotti, Anna M. Stabile, Alessandra Pistilli, Claudia Montagnoli, Maria T. Chiarelli & Ettore Mearini. (2009) Novel localization of low affinity NGF receptor (p75) in the stroma of prostate cancer and possible implication in neoplastic invasion: An immunohistochemical and ultracytochemical study. The Prostate 70:5, pages 555-561.
Crossref
Crossref
E. Nilsson, G. Dole & M. K Skinner. (2009) Neurotrophin NT3 promotes ovarian primordial to primary follicle transition. Reproduction 138:4, pages 697-707.
Crossref
Crossref
Maria Gabriella Brasca, Nadia Amboldi, Dario Ballinari, Alexander Cameron, Elena Casale, Giovanni Cervi, Maristella Colombo, Francesco Colotta, Valter Croci, Roberto D’Alessio, Francesco Fiorentini, Antonella Isacchi, Ciro Mercurio, Walter Moretti, Achille Panzeri, Wilma Pastori, Paolo Pevarello, Francesca Quartieri, Fulvia Roletto, Gabriella Traquandi, Paola Vianello, Anna Vulpetti & Marina Ciomei. (2009)
Identification of
N
,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1
H
-pyrazolo[4,3-
h
]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase Inhibitor
. Journal of Medicinal Chemistry 52:16, pages 5152-5163.
Crossref
Crossref
Catherine Liebig, Gustavo Ayala, Jonathan A. Wilks, David H. Berger & Daniel Albo. (2009) Perineural invasion in cancer. Cancer 115:15, pages 3379-3391.
Crossref
Crossref
Kenneth Thress, Terry MacIntyre, Haiyun Wang, Dave Whitston, Zhong-Ying Liu, Ethan Hoffmann, Tao Wang, Jeffrey L. Brown, Kevin Webster, Charles Omer, Peter E. Zage, Lizhi Zeng & Patrick A. Zweidler-McKay. (2009) Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway. Molecular Cancer Therapeutics 8:7, pages 1818-1827.
Crossref
Crossref
. (2008) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 15:3, pages 284-314.
Crossref
Crossref
Rabindranath Tripathy, Thelma S. Angeles, Shi X. Yang & John P. Mallamo. (2008) TrkA kinase inhibitors from a library of modified and isosteric Staurosporine aglycone. Bioorganic & Medicinal Chemistry Letters 18:12, pages 3551-3555.
Crossref
Crossref
Hubert Hondermarck. (2008) Nerve Growth Factor: The Dark Side of the Icon. The American Journal of Pathology 172:4, pages 865-867.
Crossref
Crossref
S. Sigala, S. Bodei, C. Missale, D. Zani, C. Simeone, S. Cosciani Cunico & P.F. Spano. (2008) Gene expression profile of prostate cancer cell lines: Effect of nerve growth factor treatment. Molecular and Cellular Endocrinology 284:1-2, pages 11-20.
Crossref
Crossref